Patient-rated suitability of a new electronic device for subcutaneous injection of interferon beta-1a in relapsing multiple sclerosis: Results from an international, multicentre, single-arm, open-label, twelve week, Phase IIIb trial

Authors
Category Primary study
JournalJournal of the Neurological Sciences
Year 2009
This article has no abstract
Epistemonikos ID: 04161696b76e35920b48209722d0360e2fe94237
First added on: Mar 01, 2025